As of November 7, 2026, Dogwood Therapeutics, Inc. is a publicly traded company (Nasdaq: DWTX). Sealbond Limited reports holding 75.2%, a majority of its shares. No bankruptcy or receivership appears in its SEC Form 8-K filings. Passive holders reporting on Schedule 13G include Armistice Capital (9.99%) (Schedule 13D/A, October 27, 2026).
Is this your company?
About to sign with, pay or invest in Dogwood Therapeutics, Inc.? See the free Snapshot first.
Free to see. No signup.
Is Dogwood Therapeutics, Inc. a real, registered company?
- Dogwood Therapeutics, Inc. files with the SEC under CIK 1818844 (its SEC filings).
- Its shares are listed under the ticker DWTX on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in Alpharetta, Georgia, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Dogwood Therapeutics, Inc. in our court records and SEC 8-K records (as of 2026-11-07).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Sealbond Limited (filed 2026-10-27).
Who are Dogwood Therapeutics, Inc.'s owners and officers?
Dogwood Therapeutics, Inc.: incorporated in Delaware; business address in Alpharetta, Georgia; industry Pharmaceutical Preparations (Schedule 13D/A, 2026-10-27).
| Report | Holder | Share |
|---|---|---|
| Schedule 13D/A, 2026-10-27 | Sealbond Limited | 75.2% |
| Schedule 13D/A, 2026-10-21 | Sealbond Limited | 72.3% |
| Schedule 13G/A, 2026-08-14 | Armistice Capital, LLC | 9.99% |
| Schedule 13G, 2026-05-15 | Armistice Capital, LLC | 9.99% |
| Schedule 13D/A, 2025-11-25 | Sealbond Limited | 83% |
Questions about who owns Dogwood Therapeutics, Inc.
Who owns Dogwood Therapeutics, Inc.?
On this page, 2 holders' latest ownership filings report 5% or more of Dogwood Therapeutics, Inc.: Sealbond Limited (75.2%, Schedule 13D/A, filed 2026-10-27) and Armistice Capital, LLC (9.99%, Schedule 13G/A, filed 2026-08-14).
Who are the largest shareholders of Dogwood Therapeutics, Inc.?
By the share each holder's latest filing reports, the largest holders of Dogwood Therapeutics, Inc. on this page are Sealbond Limited (75.2%) and Armistice Capital, LLC (9.99%).
When did Sealbond Limited buy into Dogwood Therapeutics, Inc.?
The filings give report dates, not purchase dates. The earliest filing from Sealbond Limited on this page is the Schedule 13D/A, filed 2025-11-25, reporting 83%; its latest, Schedule 13D/A filed 2026-10-27, reports 75.2%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 5 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Dogwood Therapeutics, Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Dogwood Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Dogwood Therapeutics, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
7 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own Dogwood Therapeutics, Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- Sealbond Ltd, a director and 10% owner: 28,763,331 shares (75.2% of shares outstanding), 25,920,693 held directly and 2,842,638 indirectly, on a joint filing (Form 4, 2026-10-27).
- Conjoint Inc., a director and 10% owner: 28,763,331 shares (75.2% of shares outstanding), 25,920,693 held directly and 2,842,638 indirectly, on a joint filing (Form 4, 2026-10-27).
- CK Life Sciences Intl (Holdings) Inc, a director and 10% owner: 28,763,331 shares (75.2% of shares outstanding), 25,920,693 held directly and 2,842,638 indirectly, on a joint filing (Form 4, 2026-10-27).
Shares outstanding: 38,227,913 as of 2026-11-03, from the company's latest SEC cover page.
How much has Dogwood Therapeutics, Inc. raised?
No fundraising or offering filing from Dogwood Therapeutics, Inc. is on file with us.
Keep reading
More on Dogwood Therapeutics, Inc. and the records around it.
Dogwood Therapeutics, Inc. elsewhere on the record
- 5%+ stake filings Oct 2026
Companies that share a holder
- Armistice Capital, LLC also filed stake reports on 120 other companies: Autolus Therapeutics plc (Aug 2026), Bicycle Therapeutics plc (Aug 2026), BioXcel Therapeutics, Inc. (Aug 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/dogwood-therapeutics